- call +1-201-465-4211
- email sales@mrinsights.biz
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
Scope of the Report:
The classification of Ursodeoxycholic Acid Drug Product includes Capsule and Tablet. And the proportion of Capsule in 2017 is about 94.8%, and the proportion is in decreasing trend from 2013 to 2018, In China, the major product is tablet, and with low concentration UDCA, and the price is also low than other manufacturers. The major products of Dr. Falk Pharma, Daewoong Pharmaceutical, Teva are capsule.
Ursodeoxycholic Acid Drug Product can be applied in Gallstone, Hepatopathy, Biliary Disease and Other. The most of Ursodeoxycholic Acid Drug Product is used in Gallstone, and the market share of that is about 36.5% in 2017.
North America is the largest sales place, with a sales market share nearly 30% in 2017. Following North America, Europe is the second largest sales place with the Sales market share of 22.1%. Ursodeoxycholic Acid Drug Product market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.
Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, etc. are the global leading manufactures in the world. In the future, more generic manufacturers will enter into this industry.
In North America, Epic Pharma is leading manufacturers, Teva, Lannett and Mylan are major suppliers of Ursodeoxycholic Acid Drug Product in USA market. In China, Dr. Falk Pharma is leading manufacturers, the market share is about 81% in 2017. In Japan, Mitsubishi Tanabe Pharma is leading manufacturers, the market share is about 52% in 2017. In Korea, Daewoong Pharmaceutical is leading manufacturers, the market share is about 86.1% in 2017
The worldwide market for Ursodeoxycholic Acid Drug Product is expected to grow at a CAGR of roughly 11.9% over the next five years, will reach 1900 million US$ in 2024, from 970 million US$ in 2019, according to a new study.
This report focuses on the Ursodeoxycholic Acid Drug Product in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Capsule
Tablet
Market Segment by Applications, can be divided into
Gallstone
Hepatopathy
Biliary Disease
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ursodeoxycholic Acid Drug Product product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ursodeoxycholic Acid Drug Product, with price, sales, revenue and global market share of Ursodeoxycholic Acid Drug Product in 2017 and 2018.
Chapter 3, the Ursodeoxycholic Acid Drug Product competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ursodeoxycholic Acid Drug Product breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ursodeoxycholic Acid Drug Product market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ursodeoxycholic Acid Drug Product sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Ursodeoxycholic Acid Drug Product Introduction
1.2 Market Analysis by Type
1.2.1 Capsule
1.2.2 Tablet
1.3 Market Analysis by Applications
1.3.1 Gallstone
1.3.2 Hepatopathy
1.3.3 Biliary Disease
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Dr. Falk Pharma
2.1.1 Business Overview
2.1.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Daewoong Pharmaceutical
2.2.1 Business Overview
2.2.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva
2.3.1 Business Overview
2.3.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Epic Pharma
2.4.1 Business Overview
2.4.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Epic Pharma Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Mitsubishi Tanabe Pharma
2.5.1 Business Overview
2.5.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Lannett
2.6.1 Business Overview
2.6.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lannett Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Mylan
2.7.1 Business Overview
2.7.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mylan Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Bruschettini
2.8.1 Business Overview
2.8.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bruschettini Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Impax
2.9.1 Business Overview
2.9.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Impax Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Shanghai Pharma
2.10.1 Business Overview
2.10.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Grindeks
2.11.1 Business Overview
2.11.2 Ursodeoxycholic Acid Drug Product Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Grindeks Ursodeoxycholic Acid Drug Product Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Ursodeoxycholic Acid Drug Product Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Ursodeoxycholic Acid Drug Product Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Ursodeoxycholic Acid Drug Product Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Ursodeoxycholic Acid Drug Product Manufacturer Market Share in 2018
3.3.2 Top 6 Ursodeoxycholic Acid Drug Product Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Ursodeoxycholic Acid Drug Product Market Analysis by Regions
4.1 Global Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Regions
4.1.1 Global Ursodeoxycholic Acid Drug Product Sales and Market Share by Regions (2014-2019)
4.1.2 Global Ursodeoxycholic Acid Drug Product Revenue and Market Share by Regions (2014-2019)
4.2 North America Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
4.3 Europe Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
4.5 South America Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
5 North America Ursodeoxycholic Acid Drug Product by Country
5.1 North America Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Country
5.1.1 North America Ursodeoxycholic Acid Drug Product Sales and Market Share by Country (2014-2019)
5.1.2 North America Ursodeoxycholic Acid Drug Product Revenue and Market Share by Country (2014-2019)
5.2 United States Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
5.3 Canada Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
5.4 Mexico Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
6 Europe Ursodeoxycholic Acid Drug Product by Country
6.1 Europe Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Country
6.1.1 Europe Ursodeoxycholic Acid Drug Product Sales and Market Share by Country (2014-2019)
6.1.2 Europe Ursodeoxycholic Acid Drug Product Revenue and Market Share by Country (2014-2019)
6.2 Germany Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
6.3 UK Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
6.4 France Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
6.5 Russia Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
6.6 Italy Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
7 Asia-Pacific Ursodeoxycholic Acid Drug Product by Country
7.1 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Ursodeoxycholic Acid Drug Product Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Ursodeoxycholic Acid Drug Product Revenue and Market Share by Country (2014-2019)
7.2 China Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
7.3 Japan Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
7.4 Korea Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
7.5 India Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
8 South America Ursodeoxycholic Acid Drug Product by Country
8.1 South America Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Country
8.1.1 South America Ursodeoxycholic Acid Drug Product Sales and Market Share by Country (2014-2019)
8.1.2 South America Ursodeoxycholic Acid Drug Product Revenue and Market Share by Country (2014-2019)
8.2 Brazil Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
8.3 Argentina Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
8.4 Colombia Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
9 Middle East and Africa Ursodeoxycholic Acid Drug Product by Countries
9.1 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Ursodeoxycholic Acid Drug Product Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
9.3 Turkey Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
9.4 Egypt Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
9.5 Nigeria Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
9.6 South Africa Ursodeoxycholic Acid Drug Product Sales and Growth Rate (2014-2019)
10 Global Ursodeoxycholic Acid Drug Product Market Segment by Type
10.1 Global Ursodeoxycholic Acid Drug Product Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Ursodeoxycholic Acid Drug Product Sales and Market Share by Type (2014-2019)
10.1.2 Global Ursodeoxycholic Acid Drug Product Revenue and Market Share by Type (2014-2019)
10.2 Capsule Sales Growth and Price
10.2.1 Global Capsule Sales Growth (2014-2019)
10.2.2 Global Capsule Price (2014-2019)
10.3 Tablet Sales Growth and Price
10.3.1 Global Tablet Sales Growth (2014-2019)
10.3.2 Global Tablet Price (2014-2019)
11 Global Ursodeoxycholic Acid Drug Product Market Segment by Application
11.1 Global Ursodeoxycholic Acid Drug Product Sales Market Share by Application (2014-2019)
11.2 Gallstone Sales Growth (2014-2019)
11.3 Hepatopathy Sales Growth (2014-2019)
11.4 Biliary Disease Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Ursodeoxycholic Acid Drug Product Market Forecast (2019-2024)
12.1 Global Ursodeoxycholic Acid Drug Product Sales, Revenue and Growth Rate (2019-2024)
12.2 Ursodeoxycholic Acid Drug Product Market Forecast by Regions (2019-2024)
12.2.1 North America Ursodeoxycholic Acid Drug Product Market Forecast (2019-2024)
12.2.2 Europe Ursodeoxycholic Acid Drug Product Market Forecast (2019-2024)
12.2.3 Asia-Pacific Ursodeoxycholic Acid Drug Product Market Forecast (2019-2024)
12.2.4 South America Ursodeoxycholic Acid Drug Product Market Forecast (2019-2024)
12.2.5 Middle East and Africa Ursodeoxycholic Acid Drug Product Market Forecast (2019-2024)
12.3 Ursodeoxycholic Acid Drug Product Market Forecast by Type (2019-2024)
12.3.1 Global Ursodeoxycholic Acid Drug Product Sales Forecast by Type (2019-2024)
12.3.2 Global Ursodeoxycholic Acid Drug Product Market Share Forecast by Type (2019-2024)
12.4 Ursodeoxycholic Acid Drug Product Market Forecast by Application (2019-2024)
12.4.1 Global Ursodeoxycholic Acid Drug Product Sales Forecast by Application (2019-2024)
12.4.2 Global Ursodeoxycholic Acid Drug Product Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Ursodeoxycholic Acid Drug Product Picture
Table Product Specifications of Ursodeoxycholic Acid Drug Product
Figure Global Sales Market Share of Ursodeoxycholic Acid
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
